Looking Forward In the MD&A the company stated that "The increase in operating revenues and significant decrease in costs have extended into at least the first quarter of the new 2015 year."
This tells us that Q1 2015 in terms of sales volume will be strong.
"Innovotech’s immediate goal is to grow the market for its contract research service in human health and to expand that business into the oil and gas industry. This activity generated a profit for the Company in the final quarter of 2014 and it has the potential to make 2015 a year in which Innovotech earns a profit."
In the MD&A the company stated that “The stronger US dollar also positively affected the financial results as a significant amount of the Company’s revenue is denominated in US dollars.” There was a sharp decline in the CAD/USD right at the start of Q1 2015 so this will definitely give boost to the sales!
And finally, they have clearly established a new goal,telling us that they won't burn more money on r&d/products and will focus and their strengths and profitability.
"The goal established is clear: Innovotech will build a business around its expertise in microbiology, particularly in respect to biofilms, by providing the leadership and services that are in demand in a variety of industries."
GLTA and may 2015 be a prosperous year for Innovotech's investors. Cheers